While some authors consider the concentration of CEA and other markers such as CA125 (cancer antigen 125) or CA19-9 (cancer antigen 19-9) as complementary diagnostics in oncology, others believe that since their serum and ascites concentrations are correlated, they do not add any clinical benefit [22,28]. The gene discussed is MUC16; the disease is cancer.